Conclusion
In summary, the role of drugs in patients with burn injuries is to help maintain adequate nutrition, and to control burn wound sepsis. This can be achieved by the judicious use of topical antimicrobial agents, monitored by regular culture and sensitivity testing. Systemic antibiotics play no part in prophylaxis but are essential for the control of septicaemia.
Similar content being viewed by others
References
McManus, W.F.; Mason, A.D. and Pruitt, B.A.: Subeschar antibiotic infusion in the treatment of burn wound infection. Journal of Trauma 20: 1021–1023 (1980).
Pegg, S.P.; Ramsay, K.; Meldrum, L. and Laundy, M.: Clinical comparison of maphenide and silver sulphadiazine. Scandinavian Journal of Plastic and Reconstructive Surgery 13: 95–101 (1979).
Pruitt, B.A. and Goodwin, C.W.: Stress ulcer disease in the burned patient. World Journal of Surgery 5: 209–222 (1981).
Snelling, C.F.T.: Comparative evaluation of povidone-iodine aerosol foam solution and silver sulphadiazine cream as prophylactic topical antibacterial agents for treatment of the burn wound. Burns 7: 143–149 (1980).
Spebar, M.J. and Pruitt, B.A.: Candidiasis in the burned patient. Journal of Trauma 21: 237–239 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pegg, S.P. The Role of Drugs in Management of Burns. Drugs 24, 256–260 (1982). https://doi.org/10.2165/00003495-198224030-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198224030-00006